04.16.26 -- Prioritizing Quality, Fit, And Supplier Reliability In CGT Materials

Learn how outsourcing cell culture media and buffers removes bottlenecks, freeing specialized CDMO resources. Ensure consistency, accelerate timelines, and streamline GMP readiness for client success.

Sterility testing is susceptible to contamination, resulting in costly false positives, batch failures, and production delays. Explore how isolator technology provides a robust barrier to protect personnel and patients alike.

Improve non-viral gene editing outcomes in cell therapy. Address key challenges like cell viability and thermal damage with an innovative post-electroporation approach designed to improve performance.

Mycoplasma contamination poses a significant risk to biopharmaceutical products and patient safety. See how implementing a rapid NAT-based testing method can enhance efficiency and quality control.

Product-related impurities hinder the potential of AAV-based gene therapies. Understand how refined cell line development and process optimization strategies are improving rAAV production.

Reliable NGS results depend on high-quality input material. Check out how automated electrophoresis and integrity metrics streamline QC processes to support confident, data-driven decisions.

Sensitive digital PCR methods enable confident detection of low‑abundance iPSC markers. Gain insight into how these capabilities support more reliable monitoring and quality assessment.

Current cell harvest techniques in allogeneic manufacturing face limitations, including scalability issues and cell damage. Grasp why evolving your harvest strategy is essential for achieving high-quality, scalable production.